Chiquita Brooks-LaSure, CMS administrator (Chip Somodevilla/Getty Images)
May 6, 2024 03:15 PM EDT
Pharma
FDA+

In­dus­try groups cri­tique new guid­ance for Medicare drug price ne­go­ti­a­tions in 2027

Nicole DeFeudis

Editor

The Cen­ters for Medicare & Med­ic­aid Ser­vices pro­posed a num­ber of changes to its Medicare ne­go­ti­a­tion guid­ance on Fri­day, some of which would af­fect how …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times